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Abstract
Angiogenesis is the process by which new blood vessels are formed from existing vessels. Mammalian populations,
including humans and mice, harbor genetic variations that alter angiogenesis. Angiogenesis-regulating gene variants can
result in increased susceptibility to multiple angiogenesis-dependent diseases in humans. Our efforts to dissect the
complexity of the genetic diversity that regulates angiogenesis have used laboratory animals due to the availability of
genome sequence for many species and the ability to perform high volume controlled breeding. Using the murine corneal
micropocket assay, we have observed more than ten-fold difference in angiogenic responsiveness among various mouse
strains. This degree of difference is observed with either bFGF or VEGF induced corneal neovascularization. Ongoing
mapping studies have identified multiple loci that affect angiogenic responsiveness in several mouse models. In this study,
we used F2 intercrosses between C57BL/6J and the 129 substrains 129P1/ReJ and 129P3/J, as well as the SJL/J strain, where
we have identified new QTLs that affect angiogenic responsiveness. In the case of AngFq5, on chromosome 7, congenic
animals were used to confirm the existence of this locus and subcongenic animals, combined with a haplotype-based
mapping approach that identified the pink-eyed dilution mutation as a candidate polymorphism to explain AngFq5. The
ability of mutations in the pink-eyed dilution gene to affect angiogenic response was demonstrated using the p-J allele at
the same locus. Using this allele, we demonstrate that pink-eyed dilution mutations in Oca2 can affect both bFGF and VEGF-
induced corneal angiogenesis.
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Introduction
Angiogenesis is the process by which new vessels are generated
from existing vasculature. In adult tissues it is rare; however it can
be initiated by a number of normal and pathological processes
including wounding, reproduction, cancer, macular degeneration,
and cardiovascular disease. Angiogenesis is regulated by a variety
of signaling molecules including VEGF, bFGF, and angiopoietins.
There are a number of in vivo assays that can measure the
angiogenic response to a particular stimulus. Among these is the
corneal neovascularization assay. This assay takes advantage of
the avascular field of the cornea as a platform in which to induce
blood vessel growth. Early studies used tumor pieces to induce this
growth, while later assays induced growth using slow-release
pellets containing angiogenic growth factors.
Among the earliest described angiogenic proteins is bFGF [1].
bFGF induces angiogenesis largely by activating classical tyrosine
kinase signaling pathways downstream of its congnate receptors
FGFR1-4, with other pathways also activated [2]. Among the
downstream mediators of bFGF–induced angiogenesis in the
cornea is VEGF [3]. We have observed significant quantitative
differences among common inbred mouse strains in their response
to both bFGF [4,5] and VEGF [3,6]. Our initial efforts at
mapping QTLs for these traits included several F2 intercrosses.
Here we report the results of F2 mapping studies, including the
identification of a new genetic modulator of angiogenic signaling.
Efforts involving recombinant-inbred strains that were initiated
later, but completed earlier have been reported previously [3,4].
The pink-eyed dilution mutation in the Oca2 gene contained in
the P locus is one of the oldest described in mice and, along with
the albino mutation in tyrosinase, was involved in the earliest
descriptions of linkage [7]. The mutation arose in the Asiatic
mouse substrain Mus musculus molossinus and was introduced into
common laboratory strains as a result of the 19
th century mouse
trade [8]. A wide variety of additional alleles are known at the P
locus, all of which result in some level of hypopigmentation in
mice. In humans, polymorphisms in an enhancer upstream of
OCA2 play a major role in determining eye color. Individuals
bearing the less active C/C genotype at rs12913832 exhibit
lighter/blue eye color [9]. In addition, an R419Q polymorphism
in the protein itself also results in lighter eye color [9].
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The rate limiting step in this process is the oxidation of tyrosine to
dopaquinone, which is catalyzed by tyrosinase (the product of the
c locus). Dopaquinone is then rearranged and further oxidized by
sequential actions of dopachrome tautomerase and tyrosinase-
related protein 1 (the product of the b locus) [10]. The resulting
molecules spontaneously polymerize into the black pigment
eumelanin. Alternatively, in the absence of the latter two enzymes,
the reaction of dopaquinone with cysteine or glutathione leads to
the production of the sulfur-containing, reddish-brown pigment
pheomelanin [10]. The role of the Oca2 protein in this process is
currently incompletely defined. It is homologous to several 12-
transmembrane-domain transporter proteins [11]. In melanocytes
lacking active p-protein, tyrosinase fails to mature and localize
properly [12]. This results in protein cleavage and secretion of
active tyrosinase and melanin. As a result, mice bearing the p-
mutation show higher circulating levels of pigment precursors
such as 5-S-cysteinyldopa (5-S-CD) and dihydroxyindolecarboxylic
(DHICA) acid than fully pigmented animals [13].
Here we outline studies aimed at identifying the nature of
inheritance of angiogenic responsiveness, identifying loci that
control for that responsiveness, and identifying specific genetic
changes within one of those loci that affect the angiogenic
response.
Results
In all our crosses we used C57BL/6J as one of the parental
strains. Our initial attempt at mapping differences in angiogenic
responsiveness was done using 129P1/ReJ mice. The angiogenic
response of F2 animals was determined using the corneal
neovascularization assay [14] using a dose of 10 ng bFGF. This
dose was chosen because it would keep the angiogenic response of
both parental strains within the linear range of the assay (,0.4–
2.2 mm2) [14] and thus was likely to keep most of the progeny
within this range as well. We had hoped that the large phenotypic
difference between this strain and C57BL/6J was the result of a
few polymorphisms in major genes that would be easily identified,
however this was not the case. In subsequent years, we have
identified a large number of loci that affect angiogenesis
[3,4,15,16] which may explain why no individual strong loci were
identified in the C57BL/6J6129P1/ReJ cross. Nevertheless, by
analyzing 77 F2 animals from this cross, we observed markers with
uncorrected p values ,0.05 for association between vessel area
and genotype on chromosomes 1 (near D1Mit218), 7 (between
D7Mit76 and D7Mit105), 10 (near D10Mit298), 11 (near
D11Mit78), 14 (between D14Mit234 and D14Mit229, and X (See
Figure 1/Table 1). To assess whether any of these loci exhibited
genome-wide statistical significance, we turned to interval map-
ping. This demonstrated that regions on Chromosomes 1 and 7
exhibited LR scores greater than the traditional cut-off for
suggestive linkage of 11.5 (equivalent to a LOD score of 2.5),
however permutation testing revealed that none of these was
significant at the genome-wide level. Composite interval mapping
showed an additional region of linkage on the proximal portion of
chromosome 2 that may correspond to AngVq2 [4]. (Figure S1).
The next cross examined was with 129P3/J, which was also
assessed at 10 ng bFGF. Simple association tests for each of the
markers demonstrated uncorrected p values ,0.05 for regions on
chromosome 7, proximal 12 (up to D12Mit46), and 14 (between
D14Mit228 and D14Mmit198). (See Figure 2/Table 2). In interval
mapping, the linked region on chromosome 12 exhibited the
strongest effect, with an estimated effect on vessel area of
,0.6 mm
2. On Chr. 14, we found linkage to a region centered
on D14Mit265 that appears to reduce vessel area by about
0.4 mm
2 in 129 mice. This region exceeded the genome-wide
permutation threshold for p,0.05 of 17.3. Weak linkages in this
cross that are of interest because they may confirm linkage
identified in other crosses, include one at D18Mit188. This region
corresponds to AngFq4 in the BXD RI cross [3]. We also see a
weak linkage peak on Chromosome 7 in this cross.
To test the role of parental sex we did a reciprocal cross using
C57BL/6J and 129P3/J animals and found that, in males only,
the F1 value was dependent on the genetic background of the
father, suggesting that in this cross one of the sex chromosomes
bears a locus that affects angiogenesis (Figure S2). This was
confirmed using the 129S1.B6,Y. strain (a kind gift of Dr.
Joseph Nadeau) which has the C57BL/6J Y chromosome on a
129S1/SvImJ background. When angiogenesis in these strains was
compared using experiments with 80 ng bFGF pellets, we
observed no significant difference in angiogenic response, likely
because the response of both strains was outside the linear range of
the assay. Consistent with this notion, when the angiogenic
response of 129S1.B6,Y. was compared with that of the 129S1/
SvImJ parent using a 20 ng bFGF pellet, we observed a 22%
increase in angiogenic response, consistent with the difference
observed between F2 animals with 129 vs. B6 Y chromosomes
(Figure 3a,b).
Our final crosses involved SJL/J and C57BL/6J mice. We
performed three distinct F2 crosses (72, 66, and 186 animals)
between these strains resulting in 325 animals available for
analysis. The angiogenic response of the resulting animals was
determined using the corneal neovascularization assay [14] using a
dose of 80 ng bFGF. As with the other crosses, the data, as
measured by vessel area, showed a distribution that did not differ
significantly from normality as determined by a Shapiro-Wilk test.
The genotype of these animals at 112 loci across the genome
was determined using microsatellite markers. In the initial cross
(73 animals), association was observed between 15 markers and
differences in angiogenic response (Table S1). Interval mapping
using data from the first cross demonstrates statistically significant
linkage to distal chromosome 5 (between D5Mit158 and D5Mit99)
and proximal chromosome 7 (near D7Mit20, Figure S3). Two
additional crosses were undertaken to confirm these results. As
animals from these crosses were added to the map, linkage to
chromosome 7 was strengthened, while linkage to chromosome 5
was weakened until it was no longer significant. In the complete
data set, association with an uncorrected P,0.05 between animal
genotype and vessel area was observed at markers on chromo-
somes 1, 3, 5, 7, 11, and 17 (Table 3). Interval mapping on the full
data set revealed a single region of genome-wide highly significant
linkage on chromosome 7 that can explain approximately 10% of
the variance in this cross (Figure 4). This peak was present when
using several different measures of corneal angiogenesis, indicating
that the mapping is not sensitive to the precise measure of vessel
growth used (Figure S4). The use of more advanced mapping
techniques, including composite interval mapping [17,18], and
multiple interval mapping [19] failed to reveal additional areas of
statistically significant linkage, though several regions of suggestive
linkage were identified.
Based on the results from the first cross, animals congenic for
the linked region on chromosome 5 and similar congenics for the
chromosome 7 region were generated by repeated backcross of
males heterozygous for these regions to C57BL/6J females.
Because of decreasing support for linkage on chromosome 5 in
the second and third F2 crosses, backcrossing for these congenics
was terminated at seven generations. These animals showed no
difference in angiogenic response when compared to C57BL/6J
Pink-Eyed Dilution Mutations Alter Angiogenesis
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measure (Figure S5). We thus conclude that there are no genetic
polymorphisms between SJL/J and C57BL/6J animals that alter
bFGF-induced angiogenesis within this region of chromosome 5.
Several chromosome 7 congenics (Figure 5) were also generated
as outlined in Materials and Methods. These strains exhibited a
decrease in bFGF-induced angiogenesis when compared to
C57BL/6J controls, with the B6 allele exhibiting partial
dominance (Figure S6). In addition, intercrosses of 8
th generation
backcross animals which contained SJL/J congenic regions on
both chromosome 7 and the Y chromosome were further
suppressed, when compared to animals containing either region
alone, indicating that the chromosome 7 region and the Y
chromosome region exhibit additive effects. Together, these results
indicate that there are genetic differences between SJL/J and
C57BL/6J animals on chromosome 7 near the pink-eyed dilution
locus that affect the angiogenic response. We have named the
chromosome 7 QTL AngFq5.
Classical mouse strains including the C57, SJL, and 129 strains
are the result of inbreeding of a few small populations. As a result
they share large genomic regions that are identical by descent.
Using data from the mouse HapMap project, we determined that
a genomic region surrounding the pink-eyed dilution locus is
shared by several strains including SJL/J, 129P2/OlaHsD, and
129X1/SvJ. In this analysis, data from the closely related 129P2/
OlaHsD strain was used in place of 129P3/J and 129P1/ReJ
strain data because dense genotyping was unavailable at the time
for the latter strains.
Based on the observation of shared haplotype among these
strains, and the observation that both of the 129 substrain crosses
identified linkage to the same region on chromosome 7 (albeit at
local, but not genome-wide, significance levels), we sought to
determine whether C57BL mice bearing 129 congenic regions
might also bear the SJL allele of AngFq5. We obtained the
B10.129P(21 M) congenic line [20], as well as several subcongenic
lines (designated R81, R82, R84, and R06) from Dr. D.
Roopenian (Jackson Laboratories, Bar Harbor Maine). In
addition, we obtained the B6.129X1-Fcgrt
tm1Dcr strain (labeled
B6.129,FcRn. in the figure) which contains a knocked out Fc-
gamma receptor, as well as a portion of the surrounding 129X1/
SvJ genome on a C57BL/6J background. Corneal neovascular-
ization assays on these strains demonstrated that B10.129P(21 M)
and R06 show reduced angiogenic responsiveness compared to
control animals and thus that they bear the SJL allele at AngFq5
(Figure 3C,E). Analysis of the congenic regions in these strains
reduced the AngFq5 critical region to approximately 22 Mbp
(Figure 5). Of this, ,75% was deprioritized either because SJL/J
shares haplotype with C57BL/6J, or because SJL/J does not share
haplotype with 129P2/OlaHsD (a close relative of the 129P3/J
and 129P1/ReJ strains used in the initial crosses). This resulted in
4 regions of appropriate haplotype containing 1, 15, 7, and 2
annotated genes distributed across a total of 5.5 Mbp. Of these,
only 2 exhibited SNPs predicted to alter amino-acid sequence
(cSNPS). Herc2 (hect domain and RCC1-like domain 2) exhibited
a K3566R polymorphism and Oca2 exhibited the L266V
polymorphisms that results in the pink-eyed dilution phenotype
(Figure 5).
To directly test whether a pink eyed dilution mutation can
suppress angiogenesis, we used the p-J mutation. This mutation
arose spontaneously at The Jackson Laboratory on a C3H
background. As a result, C3H and C3H
p–J represent a pair of
strains that differ only in a deletion at the pink-eyed dilution locus
Figure 1. C57BL/6J6129P1/ReJ F2 cross simple interval mapping. Whole genome simple interval map. Top: likelihood ratio statistic or
likelihood of a region being linked to bFGF-induced corneal neovascularization. Dashed line indicates P=0.05 as determined by bootstrapping.
Bottom: predicted additive effect of a region on bFGF-induced corneal neovascularization.
doi:10.1371/journal.pone.0035237.g001
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the bFGF-induced vessel area in C3H and C3H
p–J animals shows
that a pink-eyed dilution mutation suppresses angiogenesis to an
extent that is sufficient to explain AngFq5 (Figure 3F). Interestingly,
in contrast to bFGF, VEGF-induced angiogenesis is potentiated by
this mutation, suggesting differences in the mechanism by which
these two angiogenesis signaling pathways are affected by the pink-
eyed dilution mutation. This is noteworthy because previous
results from BXD strains in our lab showed a strong correlation
between bFGF and VEGF-responsiveness [3], indicating that most
angiogenesis-controlling QTLs in that cross affect bFGF and
VEGF similarly. Importantly both parents in that cross bear the
wild-type pink-eyed dilution allele. Thus, the trait doesn’t
segregate in that cross.
It is also noteworthy that in contrast to intercross F2 animals
(which include animals heterozygous at one or both of the Tyr and
Oca2. loci), fully homozygous B6.SJL.M1A animals showed no
decrease in angiogenic response relative to C57BL/6J controls,
while B6.SJL.M1P animals, which contain a smaller region of SJL
chromosome 7 did show a decrease in angiogenic responsiveness
(Figure 3D). This suggests that the portion of SJL chromosome 7
not included in B6.SJL.M1P animals had either a compensating or
epistatic interaction with the polymorphism responsible for
AngFq5. Importantly, in the coat color phenotype the albino
mutation at tyrosinase interacts epistatically with pink-eyed
dilution mutation in Oca2. Animals bearing the albino mutation
are albino in appearance regardless of their genotype at Oca2.W e
have observed that, animals bearing an albino mutation show no
difference in corneal angiogenic response to bFGF [5]. Thus, the
absence of a difference in angiogenic response in B6.SJL.M1A
animals indicates that similar epistatic interactions occur in the
case of angiogenic responsiveness. It further suggests that soluble
biochemical products of pigment production play a role in the
differences in angiogenic response observed.
Discussion
Both previously published data, and the data presented here
clearly demonstrate that angiogenic responsiveness is controlled by
a large number of different polymorphic genes. It may be
instructive that Oca2 is not part of a classical angiogenesis-
regulatory pathway. This may indicate that a wide variety of
angiogenesis-regulatory pathways remain to be discovered. In
addition, it may be the consequence of the importance of
angiogenesis in reproduction and development. As a result,
polymorphisms in pathways that are central to angiogenesis may
be incompatible with long-term strain viability. Indeed, VEGF
gene knockout mice exhibit haploinsufficiency [21] and low
expressing polymorphisms in the VEGF gene are associated with
reproductive difficulties (reviewed in [16]).
Repeated identification of similar regions in independent crosses
is a useful means of establishing the robustness of linkage between
genomic regions and phenotypic traits. When the crosses are
between different strains, it has the added advantage of identifying
Table 1. Markers showing near-significant and significant association with bFGF-induced corneal neovascularization in a 77-
animal C57BL/6J6129P1/ReJ F2 cross.
Marker Chrom. cM b0 b1 F % P
D1Mit218 1 67 0.708 0.19 8.979 11% 0.004 **
D2Mit396 2 69 0.712 0.119 2.805 4% 0.098
D7Mit76 7 3.4 0.713 20.173 6.807 8% 0.011 *
D7Mit246 7 15 0.707 20.193 10.01 12% 0.002 **
D7Mit229 7 23 0.706 20.189 10.05 12% 0.002 **
D7Mit201 7 37 0.702 20.184 8.595 10% 0.004 **
D7Mit253 7 53 0.709 20.181 6.933 8% 0.01 *
D7Mit105 7 64 0.715 20.162 5.062 6% 0.027 *
D10Mit298 10 3 0.715 0.151 5.028 6% 0.028 *
D11Mit78 11 2 0.727 0.128 4.167 5% 0.045 *
D12Mit150 12 59 0.707 0.123 3.775 5% 0.056
D14Mit152 14 15 0.708 0.129 3.006 4% 0.087
D14Mit234 14 23 0.692 0.203 7.634 9% 0.007 **
D14Mit30 14 29 0.699 0.191 7.504 9% 0.008 **
D14Mit39 14 30 0.699 0.191 7.504 9% 0.008 **
D14Mit228 14 46 0.697 0.151 5.072 6% 0.027 *
D16Mit139 16 43 0.706 20.14 3.512 4% 0.065
D17Mit155 17 56 0.719 0.118 3.193 4% 0.078
D19Mit128 19 11 0.715 0.144 3.88 5% 0.053
DXMit166 20 16 0.708 20.11 3.984 5% 0.05 *
DXMit186 20 69 0.702 20.139 6.54 8% 0.013 *
Marker=marker tested; Chr.=chromosome the marker is on; %=fraction of the experimental variance attributable to genotype at the marker indicated under an
additive model; P=likelihood that there is no relationship between the marker genotype and choroidal neovascularization area (by F test), when the data are fit to the
simple linear regression model y=b0+b16+e. The results give the estimates for b0, b1 and the F statistic for each marker. b0 is approximately the average area of
C57BL/6J-allele-containing strains. b1 is an indication of the effect of substitution of the 129P1/ReJ allele at that marker. Asterisks indicate uncorrected P,0.05 (*),
P,0.01 (**), or P,0.001 (***).
doi:10.1371/journal.pone.0035237.t001
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e35237Figure 2. C57BL/6J6129P3/J F2 cross simple interval mapping. Whole genome simple interval map. Top: likelihood ratio statistic or likelihood
of a region being linked to bFGF-induced corneal neovascularization. Dashed line indicates P=0.05 as determined by bootstrapping. Bottom:
predicted additive effect of a region on bFGF-induced corneal neovascularization.
doi:10.1371/journal.pone.0035237.g002
Table 2. Markers showing near-significant and significant association with bFGF-induced corneal neovascularization in a C57BL/
6J6129P3/J F2 cross.
Marker Chrom. cM b0 b1 F % P
D7Mit76 7 3.4 0.76 20.163 4.943 7% 0.03 *
D7Mit246 7 15 0.757 20.142 3.636 5% 0.061
D7Mit318 7 37 0.755 20.168 4.491 7% 0.038 *
D7Mit62 7 43 0.751 20.213 7.008 10% 0.01 *
D7Mit126 7 50 0.76 20.189 5.470 8% 0.023 *
D7Mit105 7 64 0.76 20.168 4.482 7% 0.038 *
D12Mit105 12 6 0.783 0.258 11.97 16% 0.001 ***
D12Mit136 12 13 0.788 0.268 12.33 16% 0.001 ***
D12Mit46 12 16 0.794 0.254 11.88 16% 0.001 **
D12Mit34 12 29 0.793 0.143 3.309 5% 0.074
D14Mit14 14 10 0.784 20.144 3.290 5% 0.074
D14Mit182 14 14 0.783 20.154 3.653 5% 0.061
D14Mit228 14 46 0.766 20.165 5.315 8% 0.024 *
D14Mit265 14 48 0.763 20.184 6.486 9% 0.013 *
D14Mit198 14 54 0.766 20.177 5.265 8% 0.025 *
D14Mit75 14 54 0.758 20.142 3.482 5% 0.067
Marker=marker tested; Chr.=chromosome the marker is on; %=fraction of the experimental variance attributable to genotype at the marker indicated under an
additive model; P=likelihood that there is no relationship between the marker genotype and choroidal neovascularization area (by F test), when the data are fit to the
simple linear regression model y=b0+b16+e. The results give the estimates for b0, b1 and the F statistic for each marker. b0 is approximately the average area of
C57BL/6J-allele-containing strains. b1 is an indication of the effect of substitution of the 129P3/J allele at that marker. Asterisks indicate uncorrected P,0.05 (*), P,0.01
(**), or P,0.001 (***).
doi:10.1371/journal.pone.0035237.t002
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locus. This information can be used to identify appropriate
haplotypes bearing the alleles in question. We observed overlap
between linked regions in these crosses and two previously
identified QTLs. In the C57BL/6J6129P3/J cross, we see linkage
indicating that 129P3/J bears the DBA/2J allele at AngFq4 [3].
Similarly we show evidence that 129P1/ReJ bears the DBA/2J
allele at AngVq2 [4]. As outlined in the results section, we also see
overlap in linked regions in several of the crosses described here.
129P1/ReJ and 129P3/J share alleles at a locus on chromosome
14 that we name AngFq7. Similarly, an angiogenesis-regulating
polymorphism on the Y chromosome in several 129 strains results
in AngFq8. As outlined above, haplotype analysis allowed the
identification of the SJL allele of the Oca2 gene as a strong
candidate for AngFq5.
The mechanism by which the Oca2 gene might affect
angiogenesis is currently unclear, especially since the cornea does
not contain melanocytes. It implies an effect that extends beyond
the local microenvironment such that iris melanocytes or skin
melanocytes release factors which affect the corneal limbal vessels.
Figure 3. Angiogenic response of Congenic Strains. Differences between parental (leftmost) and congenic strains are statistically significant
(P,0.05) except when the bar for the congenic strain is colored white.
doi:10.1371/journal.pone.0035237.g003
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effect on corneal angiogenesis. Alternatively, because improperly
trafficked tyrosinase is secreted by melanocytes bearing the Oca2
p
allele [12] and tyrosinase readily generates reactive oxygen [22],
increased circulating tyrosinase may lead to increases in reactive
oxygen species. This reactive oxygen can, in turn, stimulate
endothelial cell production of VEGF as well as other endothelial
cell activity associated with angiogenesis [23,24]. Other endothe-
lial cell signaling molecules affected by ROS include phosphatases,
transcription factors and bioactive lipids [25,26].
In addition, circulating tyrosinase has the capacity to alter
circulating levels of catecholamines. Spontaneous disproportina-
tion of dopaquinone yields DOPA as one of its products. In
addition, met-tyrosinase consumes DOPA or dopamine as it is
returned to an active redox state. Finally, in addition to tyrosine,
tyrosinase can use a variety of phenols and catechols as substrates.
Since different catecholamines can produce both pro- and
antiangiogenic effects [27,28,29], circulating tyrosinase has the
potential to significantly alter the angiogenic response. Similar
differences in these known angiogenesis modulators may explain
the differential response to bFGF, due to differential effects on the
timing and nature of signaling. Alternatively these differences
might be explained by regulation of novel angiogenesis signaling
molecules by the pink-eyed dilution protein.
In humans polymorphisms in the human homolog of the Oca2
gene are associated with genetic susceptibility to melanoma [9].
Importantly, this effect may not be entirely dependent on
differences in pigmentation. OCA2 polymorphisms are associated
with differences in eye color, however, OCA2-linked differences in
melanoma susceptibility persist after controlling for eye color [30].
This indicates that differences in pigmentation and therefore UV
susceptibility may not be sufficient to explain the difference in
melanoma susceptibility. It has been suggested that subtle
differences in the quality of melanin produced, or differences in
glutathione metabolism observed in Oca2-mutant melanocytes
may account for differing disease susceptibility [30]. To this, we
add the possibility that increased VEGF angiogenic responsiveness
may affect genetic susceptibility to melanoma. An increased
angiogenic response in individuals with appropriate OCA2
genotype may allow earlier conversion of melanoma to three-
dimensional growth and thus frank disease. Extrapolating this idea
to angiogenic responsiveness in general suggests that an increased
identification and understanding of angiogenesis response alleles
may allow improved identification of individuals susceptible to
angiogenesis dependent diseases such as cancer.
Materials and Methods
Ethics Statement
All animal studies were conducted according to protocols A00-
06-046R, A03-10-075R, A06-09-078R, and A09-09-1511R ap-
proved by the Institutional Animal Care and Use Committee of
Children’s Hospital.
Figure 4. C57BL/6J6SJL/J F2 cross simple interval mapping. Whole genome simple interval map. Top: likelihood ratio statistic or likelihood of
a region being linked to bFGF-induced corneal neovascularization. Dashed line indicates P=0.05 as determined by bootstrapping. Bottom: predicted
additive effect of a region on bFGF-induced corneal neovascularization.
doi:10.1371/journal.pone.0035237.g004
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A total of 65 F2 animals were generated by intercrossing F1
progeny of 129P1/ReJ and C57BL/6J animals obtained from
Jackson Labs. The resulting animals were genotyped using 89
publicly available SSLP markers. These animals were then
phenotyped using the corneal neovascularization assay [14]. For
the 129P3/J F2 cross, we used B6129PF1/J animals commercially
available from Jackson Labs as parents. A total of 77 F2 animals
were generated, genotyped at 98 SSLP markers, and phenotyped
as above. In both 129 crosses, animals with a high inter-eye
variability (coefficient of variation .0.45) were excluded from
further analysis. C57BL/6J x SJL/J F2 animals were generated
from grandparents obtained from Jackson labs. These animals
were genotyped at 112 publicly available SSLP markers and
phenotyped as above.
Generation of Congenic Animals
B6.SJL chromosome 5 congenics were generated from C57BL/
6J x SJL/J F1 animals by selecting males in each generation that
were heterozygous at D5Mit158, D5Mit188, D5Mit213, D5Mit168,
and D5Mit43. These animals were backcrossed to C57BL/6J
females for seven generations. After the seventh backcross
generation, the animals were intercrossed to generate homozygous
congenics.
Chromosome 7 congenics were generated in a similar manner
except that animals heterozygous for D7Mit229, D7Mit211,
Table 3. Markers showing near-significant and significant association with bFGF-induced corneal neovascularization in a C57BL/
6J6SJL/J F2 cross.
Marker Chrom. cM b0 b1 F % P
D10Mit44 1 9 1.404 0.066 4.314 1% 0.039 *
D1Mit3 1 11 1.403 0.053 2.955 1% 0.087
D1Mit306 1 59 1.401 20.051 2.851 1% 0.092
D1Mit94 1 64 1.4 20.069 5.176 2% 0.024 *
D1Mit36 1 92 1.395 20.107 13.23 4% 0.000 ***
D3Mit51 3 35 1.41 0.065 4.147 1% 0.043 *
D3Mit106 3 55 1.405 0.052 2.862 1% 0.092
D5Mit205 5 45 1.409 0.077 6.144 2% 0.014 *
D5Mit338 5 59 1.407 0.061 4.236 1% 0.040 *
D5Mit158 5 62 1.407 0.073 5.336 2% 0.022 *
D5Mit188 5 64 1.407 0.077 5.645 2% 0.018 *
D5Mit168 5 78 1.403 0.061 4.261 1% 0.040 *
D5Mit99 5 80 1.403 0.06 3.776 1% 0.053
D6Mit59 6 67 1.401 20.057 3.045 1% 0.082
D6Mit294 6 73 1.401 20.051 2.845 1% 0.093
D7Mit76 7 3.4 1.402 20.061 3.919 1% 0.049 *
D7Mit246 7 15 1.401 20.111 10.99 3% 0.001 **
D7Mit270 7 18 1.4 20.123 14.77 4% ,10
23 ***
D7Mit229 7 23 1.4 20.121 16.77 5% ,10
24 ****
D7Mit145 7 26 1.4 20.132 20.46 6% ,10
25 ****
Oca2 7 28 1.4 20.135 20.98 6% ,10
25 ****
D7Mit318 7 37 1.404 20.141 24.18 7% ,10
25 ****
Tyr 7 44 1.407 20.163 31.23 9% ,10
27 ****
D7Mit126 7 50 1.405 20.155 25.3 7% ,10
26 ****
D7Mit105 7 64 1.401 20.11 13.03 4% ,10
23 ***
D7Mit12 7 66 1.4 20.089 8.23 2% 0.004 **
D10Mit180 10 64 1.405 0.061 3.822 1% 0.051
D11Mit78 11 2 1.402 20.073 5.454 2% 0.020 *
D17Mit66 17 25 1.402 20.071 4.847 1% 0.028 *
D17Mit88 17 30 1.402 20.09 8.212 2% 0.004 **
D17Mit93 17 45 1.401 20.066 4.624 1% 0.032 *
DXMit166 20 16 1.412 0.055 3.676 1% 0.056
Marker=marker tested; Chr.=chromosome the marker is on; %=fraction of the experimental variance attributable to genotype at the marker indicated under an
additive model; P=likelihood that there is no relationship between the marker genotype and choroidal neovascularization area (by F test), when the data are fit to the
simple linear regression model y=b0+b16+e. The results give the estimates for b0, b1 and the F statistic for each marker. b0 is approximately the average area of
C57BL/6J-allele-containing strains. b1 is an indication of the effect of substitution of the 129P3/J allele at that marker. Asterisks indicate uncorrected P,0.05 (*), P,0.01
(**), P,0.001 (***) or P,0.0001 (****).
doi:10.1371/journal.pone.0035237.t003
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allele at D7Mit332 were selected, and backcrossing was continued
for a full ten generations before intercrossing. In addition, at the
8
th and 9
th backcross generations, three additional lines were
generated. B6.SJL
ChrY animals were generated by selecting an N8
animal that was homozygous for the B6 allele at all of the
chromosome 7 markers for further backcrossing. B6.SJL.7M1A
animals were generated from an N8 animal that had a
recombination event between D7Mit229 and D7Mit 233. This
resulted in animals that were B6 for the proximal portion of
Chromosome 7 and had an albino coat color. B6.SJL.7M1P
animals were generated from a B6.SJL.7M1A heterozygous
animal that experienced a recombination between D7Mit233
and D7Mit62, resulting in an animals that retained the SJL/J pink-
eyed dilution allele, but had the C57BL/6J tyrosinase allele,
resulting in animals that were pink-eyed dilute in coat color.
Mapping
Windows QTL Cartographer version 2.5 [31] was used
throughout for linkage analysis. Default settings were used
throughout. Marker genotypes were obtained using PCR and
agarose gel electrophoresis. Primers for SSLP markers and
associated linkage map positions were obtained from MGI version
4.21. Simple association, interval mapping [32], and composite
Figure 5. Mapping the region responsible for AngFq5. Top: Location of the congenic regions for the congenic strains used is plotted, along
with boundary-defining markers for SJL congenics (brown). Blue indicates 129 congenics, with dark blue indicating those congenics that demonstrate
a statistically significant difference in angiogenic response. Genes are indicated next by which DNA strand they are coded by. Finally regions of shared
haplotype are indicated colored by whether the parental strains have disparate (black) or shared (grey) alleles at AngFq5. Below: Magnification of the
region of interest defined by the R82 and R06 congenics. The number of genes, and genes bearing amino-acid altering polymorphisms (cSNPs), is
indicated as are the locations of the pink-eyed dilution gene (p) and the tyrosinase gene (c). Scale is in Mbp on build 37.1 of mouse Chromosome 7.
doi:10.1371/journal.pone.0035237.g005
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using 10,000 iterations was performed for each of the three
interval mapping experiments, resulting in threshold likelihood
ratios (LR) for P,0.05 of 16.7, 17.3, and 15.6 for the C57BL/6J
cross with 129P3/J, 129P1/ReJ, and SJL/J respectively. In the
case of the SJL cross, P,0.001 corresponded to a LR of 24.8.
Haplotype Mapping
For haplotype mapping genotypes for C57BL/6J, C57BL/10J,
129P2/OlaHsD, 129X1/SvJ, and SJL/J strains were obtained
from the Broad institute hapmap website on 22 July 2009 (http://
www.broadinstitute.org/mouse/hapmap/). This file contains SNP
position information relative to NCBI build 37 of the mouse
genome, as well as genotype information for 94 different strains.
Regions of shared haplotype were determined by identifying
regions where flanking polymorphic SNPs were on average
.1 MB from a given SNP [15]. Uncalled SNPs were not included
in this analysis.
Corneal Micropocket Assay
The corneal micropocket assay was performed as described
[14,33] using pellets containing the indicated quantity of FGF2 or
160 ng carrier free human recombinant VEGF 165 (R&D
Systems, Minneapolis, Minnesota). The area of vascular response
was assessed on the fifth (FGF2) or sixth (VEGF) postoperative day
using a slit lamp. Vessel area was calculated using the formula
0.2p6VL6CH where VL is vessel length from the limbus in mm
and CH is clock hours around the cornea. Control C57BL/6J
(typically 5 mice, 10 eyes) were included in each assay to confirm
consistency. All mouse strains were obtained from Jackson
Laboratories (Bar Harbor, Maine) and were housed in Children’s
Hospital’s animal facility on standard diet and bedding until the
assay was performed.
Supporting Information
Figure S1 Composite interval mapping of the C57BL/
6J6129P1/ReJ F2 cross. Whole genome composite interval
map. Top: likelihood ratio statistic or likelihood of a region being
linked to bFGF-induced corneal neovascularization. Bottom:
predicted additive effect of a region on bFGF-induced corneal
neovascularization. The indicated likelihood ratio of 11.5 is
equivalent to a LOD score of 2.5.
(TIF)
Figure S2 Effect of parental gender on vessel area in a
1296B6 F1 cross. Pellets contain 10 ng bFGF. The increase in
vessel area in the 129B6F1 males is statistically significant (p,0.05
by ANOVA).
(TIF)
Figure S3 Simple interval mapping of the initial
C57BL/6J6SJL/J F2 cross.
(TIF)
Figure S4 Simple interval mapping of different mea-
sures of angiogenic response in the full C57BL/6J6SJL/J
F2 cross. The use of different measures of angiogenic response as
the trait to be mapped was explored. AVA is the (unadjusted)
average of vessel areas of the left and right eyes. AVL is the
average of the vessel length of the left and right eyes. NORMAVA
is the average vessel area divided by (normalized) the vessel area
measured in C57BL/6J controls assayed at the same time.
(TIF)
Figure S5 Effect of SJL alleles on vessel area in B6.SJL
Chromosome 5 N6F1 animals. Note the truncated vertical
axis. None of these differences are statistically significant
(ANOVA).
(TIF)
Figure S6 Effect of SJL alleles on vessel area in B6.SJL
Chromosome 7 N8F1 animals. Note the truncated vertical axis.
(TIF)
Table S1 Markers showing near-significant and signif-
icant association with bFGF-induced corneal neovascu-
larization in the initial C57BL/6J6SJL/J F2 cross.
(DOCX)
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